Back to top
more

Pharmaceuticals Ultrasector Profund, Service Class: (MF: PHPSX)

(NASDAQ Mutual Funds) As of Aug 21, 2026 06:01 PM ET

$40.67 USD

+0.37 (0.92%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

NA

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jul 31, 2026

Total Return %* Percentile Rank Objective
YTD 28.37 1
3 months 25.61 1
6 months 31.67 1
1 Year 98.65 2
3 Year 17.96 11
5 Year 8.21 17
10 Year 6.01 96

* Annual for three years and beyond.

Zacks Premium Research for PHPSX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

NA
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 32.02
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 7/31/2026 0.79
% Turnover 7/31/2026 388.00

Risk

3 Year 5 Year 10 Year
Beta 0.95 0.84 1.05
Alpha 3.12 -0.26 -6.63
R Squared 0.15 0.22 0.39
Std. Dev. 30.72 27.71 25.56
Sharpe 0.55 0.28 4.00

Sector / Country Weightings

As of 7/31/2026 % of Portfolio
Health 62.66
Other 31.66
Industrial Cyclical 1.63
Services 1.61
Non-Durable 1.24
Retail Trade 1.20

Portfolio Holdings

Top Equity Holdings
(As of 4/30/2026)
% of Portfolio Value (Mil$)
TOTAL*REPURCHASE AGREEMEN 27.35 0.88
ORGANON & CO 2.87 0.09
AXSOME THERAPEUTICS INC 1.80 0.06
CORCEPT THERAPEUTICS INC 1.91 0.06
ENLIVEN THERAPEUTICS INC 1.86 0.06
DEFINIUM THERAPEUTICS INC 1.63 0.05
NEKTAR THERAPEUTICS 1.61 0.05
OMEROS CORP 1.70 0.05
PERRIGO COMPANY PLC 1.67 0.05

Stock Holding % of Net Assets

As Of 4/30/2026
Total Issues 59
Avg. P/E 20.26
Avg. P/Book 6.84
Avg. EPS Growth 11.53
Avg. Market Value (Mil $) 42,639

Composition

% of Portfolio
Stocks 77.15
Foreign Stocks 3.19
Cash 28.31
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other -5.46
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 4.90
Small Value 7.43
Foreign Stock 7.48
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 10.05
Foreign Bond 13.51
High Yield Bond 0.00